Versant Ventures — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Enable Injectionsenableinjections.comin 𝕏Dec 2025SEC filingmedium confidence

Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases.

BiotechHealthtechMedical DevicesCincinnati, US

Mike Hooven(Chairman, President and CEO)John Rice(Director)Timothy Flaherty(Executive Officer)Simone Song(Director)Karen Robards(Director)Richard J D'Augustine(Director)

Board seatBeckie Robertson· per SEC Form D · $30M raise · filed Jan 2026

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.